Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

Clinical trial NCT04084366 · TERMINATED

Trial details

NCT number: NCT04084366
Sponsor: OBI Pharma, Inc
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor

Start date: 2019-11-25
Primary completion: 2023-10-27
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.